161 related articles for article (PubMed ID: 37134268)
1. An Update on the Role of Immunohistochemistry in the Evaluation of Pancreatic/Liver/Gastrointestinal Luminal Tract Disorders.
Huang J; Chen G; Li H
Arch Pathol Lab Med; 2023 Dec; 147(12):1374-1382. PubMed ID: 37134268
[TBL] [Abstract][Full Text] [Related]
2. Practical Immunohistochemistry in Neoplastic Pathology of the Gastrointestinal Tract, Liver, Biliary Tract, and Pancreas.
Wang HL; Kim CJ; Koo J; Zhou W; Choi EK; Arcega R; Chen ZE; Wang H; Zhang L; Lin F
Arch Pathol Lab Med; 2017 Sep; 141(9):1155-1180. PubMed ID: 28854347
[TBL] [Abstract][Full Text] [Related]
3. An Update on the Role of Immunohistochemistry in the Evaluation of Gastrointestinal Tract Disorders.
Robertson S; Patil DT
Adv Anat Pathol; 2020 May; 27(3):193-205. PubMed ID: 30234501
[TBL] [Abstract][Full Text] [Related]
4. The use of Cytokeratin 19 (CK19) immunohistochemistry in lesions of the pancreas, gastrointestinal tract, and liver.
Jain R; Fischer S; Serra S; Chetty R
Appl Immunohistochem Mol Morphol; 2010 Jan; 18(1):9-15. PubMed ID: 19956064
[TBL] [Abstract][Full Text] [Related]
5. Ancillary tests in the diagnosis of liver and pancreatic neoplasms.
Misdraji J; Centeno BA; Pitman MB
Cancer Cytopathol; 2018 Aug; 126 Suppl 8():672-690. PubMed ID: 30156777
[TBL] [Abstract][Full Text] [Related]
6. Application of immunohistochemistry to liver and gastrointestinal neoplasms: liver, stomach, colon, and pancreas.
Geller SA; Dhall D; Alsabeh R
Arch Pathol Lab Med; 2008 Mar; 132(3):490-9. PubMed ID: 18318589
[TBL] [Abstract][Full Text] [Related]
7. Utility of immunohistochemistry in the pancreatobiliary tract.
Lin F; Chen ZE; Wang HL
Arch Pathol Lab Med; 2015 Jan; 139(1):24-38. PubMed ID: 25549142
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical Biomarkers of Gastrointestinal, Pancreatic, Pulmonary, and Thymic Neuroendocrine Neoplasms.
Uccella S; La Rosa S; Volante M; Papotti M
Endocr Pathol; 2018 Jun; 29(2):150-168. PubMed ID: 29520563
[TBL] [Abstract][Full Text] [Related]
9. Application of immunohistochemistry in gastrointestinal and liver neoplasms: new markers and evolving practice.
Chen ZE; Lin F
Arch Pathol Lab Med; 2015 Jan; 139(1):14-23. PubMed ID: 25549141
[TBL] [Abstract][Full Text] [Related]
10. CD73 expression in normal and pathological human hepatobiliopancreatic tissues.
Sciarra A; Monteiro I; Ménétrier-Caux C; Caux C; Gilbert B; Halkic N; La Rosa S; Romero P; Sempoux C; de Leval L
Cancer Immunol Immunother; 2019 Mar; 68(3):467-478. PubMed ID: 30607549
[TBL] [Abstract][Full Text] [Related]
11. A Timely Update of Immunohistochemistry and Molecular Classification in the Diagnosis and Risk Assessment of Endometrial Carcinomas.
Wang M; Hui P
Arch Pathol Lab Med; 2021 Nov; 145(11):1367-1378. PubMed ID: 34673912
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of pancreatic ductal adenocarcinoma from chronic pancreatitis by PAM4 immunohistochemistry.
Shi C; Merchant N; Newsome G; Goldenberg DM; Gold DV
Arch Pathol Lab Med; 2014 Feb; 138(2):220-8. PubMed ID: 24476519
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Approach to Neuroendocrine Neoplasms of the Gastrointestinal Tract and Pancreas.
Uccella S; Sessa F; La Rosa S
Turk Patoloji Derg; 2015; 31 Suppl 1():113-27. PubMed ID: 26177322
[TBL] [Abstract][Full Text] [Related]
14. DOG1 (clone K9) is seldom expressed and not useful in the evaluation of pancreatic neoplasms.
Hemminger J; Marsh WL; Iwenofu OH; Frankel WL
Appl Immunohistochem Mol Morphol; 2012 Jul; 20(4):397-401. PubMed ID: 22495382
[TBL] [Abstract][Full Text] [Related]
15. A Clinicopathologic and Molecular Update of Pancreatic Neuroendocrine Neoplasms With a Focus on the New World Health Organization Classification.
Fang JM; Shi J
Arch Pathol Lab Med; 2019 Nov; 143(11):1317-1326. PubMed ID: 31509453
[TBL] [Abstract][Full Text] [Related]
16. LEF-1 is frequently expressed in colorectal carcinoma and not in other gastrointestinal tract adenocarcinomas: an immunohistochemical survey of 602 gastrointestinal tract neoplasms.
Kermanshahi TR; Jayachandran P; Chang DT; Pai R
Appl Immunohistochem Mol Morphol; 2014; 22(10):728-34. PubMed ID: 25394300
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemistry in gynecologic carcinomas: Practical update with diagnostic and clinical considerations based on the 2020 WHO classification of tumors.
Buza N
Semin Diagn Pathol; 2022 Jan; 39(1):58-77. PubMed ID: 34750021
[TBL] [Abstract][Full Text] [Related]
18. Glypican-3 expression in gastrointestinal and pancreatic epithelial neoplasms.
Mounajjed T; Zhang L; Wu TT
Hum Pathol; 2013 Apr; 44(4):542-50. PubMed ID: 23079207
[TBL] [Abstract][Full Text] [Related]
19. Claudin18.2 as a potential therapeutic target for primary ovarian mucinous carcinomas and metastatic ovarian mucinous carcinomas from upper gastrointestinal primary tumours.
Wang F; Yang Y; Du X; Zhu X; Hu Y; Lu C; Sui L; Zhao H; Song K; Yao Q
BMC Cancer; 2023 Jan; 23(1):44. PubMed ID: 36639622
[TBL] [Abstract][Full Text] [Related]
20. Endoscopic ultrasound-guided fine-needle aspiration cytology in pancreaticobiliary carcinomas: diagnostic efficacy of cell-block immunocytochemistry.
Ieni A; Todaro P; Crino SF; Barresi V; Tuccari G
Hepatobiliary Pancreat Dis Int; 2015 Jun; 14(3):305-12. PubMed ID: 26063033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]